RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Genomic Instability
Accession: DOID:9002981
browse the term
Definition: An increased tendency of the GENOME to acquire MUTATIONS when various processes involved in maintaining and replicating the genome are dysfunctional.
Synonyms: exact_synonym: Genome Instabilities; Genome Instability; Genome Stabilities; Genome Stability; Genomic Instabilities; Genomic Stabilities; Genomic Stability
primary_id: MESH:D042822
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8548770
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Fbxw7
F-box and WD repeat domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17588203
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23217256
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sprtn
SprT-like N-terminal domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25261934
NCBI chr19:52,857,612...52,864,864
Ensembl chr19:52,857,866...52,864,864
G
Sult1a1
sulfotransferase family 1A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28326452
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24976383
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Ckap5
cytoskeleton associated protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24976383
NCBI chr 3:77,491,195...77,593,300
Ensembl chr 3:77,491,276...77,593,264
G
Kif11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17974955
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Lxn
latexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25341047
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
G
Ppp2r2a
protein phosphatase 2, regulatory subunit B, alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25772433
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
G
Ppp2r5c
protein phosphatase 2, regulatory subunit B', gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25772433
NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25772433
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Rps3
ribosomal protein S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25341047
NCBI chr 1:153,778,363...153,783,663
Ensembl chr 1:153,777,472...153,783,680
G
Acvr2a
activin A receptor type 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
G
Arid1a
AT-rich interaction domain 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
G
Bax
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Hdac2
histone deacetylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Mir155
microRNA 155
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Msh3
mutS homolog 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 2:23,444,326...23,585,777
G
Msh6
mutS homolog 6
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25701956 PMID:18417481
RGD:2292505
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Msh6m1Hubr
mutS homolog 6; ENU induced mutant 1, Hubr
IMP
RGD
PMID:18417481
RGD:2292505
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17350979
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Rnf43
ring finger protein 43
ISO
associated with ascending colon cancer;DNA:nonsense mutation, frameshift mutations:CDS:multiple (human) associated with colorectal cancer, endometrial cancer;DNA:mutations:multiple (human) associated with colorectal cancer, stomach cancer;protein:decreased expression:cytoplasm (human)
RGD
PMID:32236609 PMID:25344691 PMID:26297255
RGD:151361217 , RGD:151361224 , RGD:11056888
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
G
Setd2
SET domain containing 2, histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Smc2
structural maintenance of chromosomes 2
ISO
assoc. w/gastric cancer;DNA:frameshift mutations:exon 6, exon 17:K188fsX5, T751fsX9 (human)
RGD
PMID:24483990
RGD:151356954
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Tarbp2
Tarbp2 subunit of RISC loading complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 7:133,649,118...133,654,306
Ensembl chr 7:133,649,090...133,654,314
G
Tgfbr2
transforming growth factor, beta receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7761852 PMID:25701956
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Xpo5
exportin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25701956
NCBI chr 9:14,740,182...14,778,171
Ensembl chr 9:14,740,182...14,778,171
G
Sprtn
SprT-like N-terminal domain
ISO
ClinVar Annotator: match by term: Progeroid features-hepatocellular carcinoma predisposition syndrome | ClinVar Annotator: match by term: Ruijs-Aalfs syndrome
OMIM ClinVar
PMID:12503110 PMID:25261934 PMID:25741868
NCBI chr19:52,857,612...52,864,864
Ensembl chr19:52,857,866...52,864,864
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all